Traumatic cerebral vascular injury (TCVI) is a frequent, but under-recognized, endophenotype of traumatic brain injury (TBI). It likely contributes to functional deficits after TBI and TBI-related chronic disability, and represents an attractive target for targeted therapeutic interventions. The aim of this prospective study is to assess microvascular injury/dysfunction in chronic TBI by measuring cerebral vascular reactivity (CVR) by 2 methods, functional magnetic resonance imaging (fMRI) and functional Near InfraRed Spectroscopy (fNIRS) imaging, as each has attractive features relevant to clinical utility. 42 subjects (27 chronic TBI, 15 age-and gender-matched non-TBI volunteers) were enrolled and underwent outpatient CVR testing by 2 methods, MRI-BOLD and fNIRS, each with hypercapnia challenge, a neuropsychological testing battery, and symptom survey questionnaires.
INTRODUCTION
Traumatic brain injury (TBI) is a leading cause of death and disability around the world, and affects adults and children across all socioeconomic strata. 1 In the US, head trauma is responsible for 2.8 million emergency visits, 300,000 hospitalizations, and 50,000 deaths each year. 2 Traumatic cerebrovascular injury (TCVI) is one of the most common abnormalities acutely reported in TBI patients, including mild TBI. [3] [4] [5] Neuropathology studies in patients who die with TBI uniformly find evidence of microvasculopathy, [6] [7] [8] [9] a finding which is also noted in the few pathologic studies which have focused on patients with mild TBI. 10, 11 Established neuroimaging methods enable quantitative measurement of cerebral blood flow (CBF) and cerebrovascular reactivity (CVR) in animals and humans. [12] [13] [14] Finally, TCVI is an attractive target for therapeutic intervention, as established pharmacologic and non-pharmacologic therapies with proven efficacy in improving vascular health are already available. 15 Such therapies include phosphodiesterase-5 inhibitors, 16 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors, 17 angiotensin II receptor blockers, 18 erythropoietin 19 transforming growth factor beta (TGF) inhibitors, 15 aerobic exercise, 20 dietary interventions, 21 and nutraceuticals such as omega-3 fatty acids. 22 The ready availability of these therapies highlights the need for reliable tools to measure TCVI noninvasively and sequentially.
CBF has been extensively studied after TBI in humans, mostly in the acute period within a few days of injury, 23, 24 but several studies have looked at CBF weeks to years after TBI. There is a consistent body of literature in humans indicating that deficits in CBF are common after TBI. 25 Studies using single photon emission computed tomography (SPECT) [25] [26] [27] and arterial spin labelling (ASL) 28, 29 reveal alterations in global and regional resting CBF in TBI patients of all severities.
Well-established methods also exist to study CVR non-invasively in humans, after stimuli such as hypercapnia, breath holding, or acetazolamide. 12 Transcranial Doppler (TCD), near infra-red spectroscopy (NIRS) and Magnetic Resonance Imaging (MRI) are the most popular methods in recent studies 30, 31 particularly in subjects who had experienced the TBI exposures. Functional near Infra-Red Spectroscopy (fNIRS) has been used to study CVR after TBI as well as in other neurologic conditions. [32] [33] [34] [35] Changes in CBF and associated changes in tissue concentrations of oxy-and deoxy-hemoglobin are measured by fNIRS 36 . Like TCD, fNIRS offers a very high temporal resolution, and while spatial resolution is superior to TCD, it is not as high as fMRI.
fNIRS allows for reliable CVR measurements over time during dynamic challenges that are independent of hemoglobin concentration, skull thickness and extracranial circulation. 34, 37, 38 fNIRS has also been carried out in the chronic stage of TBI, and CVR abnormalities correspond to performance on the cognitive tests. 33, 39 Our group has recently reported that CVR assessed by measuring the response of the blood oxygen level dependent (BOLD) signal to hypercapnia is reduced in chronic TBI. 38 The pattern of CVR decline noted was not diffusely symmetric, but rather multifocal. Since MRI is expensive, time consuming, non-portable, and not well suited for use in emergency departments, critical care units, and outpatient clinics, the purpose of this study is to determine how the cerebrovascular response to hypercapnia measured with NIRS correlates with measures obtained using MRI-BOLD. The ability to inexpensively and repeatedly assess CVR in brain injured patients has high potential as a biomarker of TCVI. The table 1 summarizes the demography features of our population.
MATERIELS AND METHOD

c) Hypercapnia
Each participant underwent MRI-BOLD and fNIRS sequences with CVR hypercapnia measurements according to the methods developed previously. 13, 40, 41 Hypercapnia was induced via a Douglas bag alternating between a flow of room air and 5% CO 2 mixed with room air every minute for 7 minutes total while the MRI-BOLD or fNIRS images were acquired. A long hypercapnia condition (60s) was chosen to allow EtCO2 pressure to reach a plateau before switching to Room air condition. 13 End-tidal CO 2 (EtCO 2 ) was measured continuously using a capnograph (Smith Medical, Model 9004). These conditions (5% CO 2 for no longer than one minute at a time) did not result in significant changes in mean arterial blood pressure, heart rate or oxygen saturation. 42
d) MRI
Scan: MRI was performed on a Siemens Biograph mMR, fully integrated 3T MRI/PET. Wholebrain T1-weighted 1 mm isotropic structural scans were collected using a 3D multiecho MPRAGE sequence (176 sagittal slices, 256 mm FoV, TR 2530 ms, TI 1200 ms)Fluidattenuated inversion recovery (FLAIR) images were acquired with the following parameters:
TR/TE=9090/112 ms, inversion time = 2450 ms, voxel size: 0.9x0.9x3mm 3 .
The 7 min hypercapnia challenge was done under an fMRI sequence: TR/TE=2,000/25 msec, flip angle=80°, field of view=220 x 220 mm2, matrix= 64 x 64, 36 slices, thickness=3.6 mm, no gap between slices, 210 volumes.
fMRI analysis: The BOLD response signal is delayed from the EtCO 2 13, 43 which correspond to the time needed for the blood to travel between the lungs to the cerebrovascular network. The EtCO 2 time delay is individually time shifted (with one sec step increment) to achieve the maximum correlation with the BOLD response signal. We processed voxel-by-voxel CVR maps using a general linear model, with the shifted EtCO 2 time course as the regressor to generate CVR maps (in the units of % BOLD change/mmHg CO 2 change, %/mmHg) for each subject. Lu et al previously described the full method. 44 As preprocessing step, images were spatially realigned and re-sliced to correct for head motion with SPM (realign and re-slice toolbox) and a 6mm (FWHM) Gaussian kernel was used for smoothing the resultant time series. As post processing steps, the CVR and FLAIR images were each co-registered with the MPRAGE images using SPM12.
e) fNIRS
Scan: We used a continuous wave fNIRS system (fNIRS Devices LLC, MD). The instrument consists of an array of four sources and 10 detectors, with a total of 16 source-detector pairs (see Figure 1 ). In this system all sources and detectors are molded together in a single silicon band. It collects data at two wavelengths-730 and 850 nm-with an acquisition frequency of 2 Hz. The sensor band was positioned on patient's forehead covering the prefrontal cortex (PFC) area (dorsal and inferior frontal cortical areas) 45 . The rigid montage is carefully position above the eyebrow and in the middle of the forehead. The first detector row is approximately at 3.5 cm above the nasion. This system was selected for this feasibility study because it is comfortable and easy to wear.
fNIRS analysis: NIRS light intensities at two wavelengths were then converted to changes in oxy-hemoglobin (HbO) and deoxy-hemoglobin (HbR) using the modified Beer-Lambert (MBLL) law. 46 Processing of the raw NIRS signal involved detection and removal of artifacts related to subject motion as well as respiration and heart rate. We used both median filtering and the sliding window motion artifact rejection (SMAR) to detect and remove motion artifact and saturated channels 47 . This algorithm uses presence of sharp spikes and high standard deviations of the signal (>3% temporally) to detect motion. Correlation Based Signal Improvement was also used to remove any unidirectional changes in HbO and HbR signals 48, 49 . Then, a low pass frequency filter (<0.1 Hz, Hanning window, order 20) was applied to remove high frequency contamination related to heart beat and respiration [50] [51] [52] . Afterward, signals were detrended to eliminate the slow changes in the signal.
The hemodynamic response is time delayed from the EtCO2 and, like the fMRI analysis, the temporal EtCO2 trace needs to be individually shifted with one step increment to achieve the maximum correlation with the hemoglobin signals. The time shift between the oxygenation (HbO -HbR) and EtCO 2 was also measured. CVR values for each channel is the solution of the linear equation between HbO (or HbR) and EtCO 2 using the Cholesky decomposition in MATLAB.
RESULTS
a) CVR in healthy control
The inhalation of 5% CO 2 during 60s is accompanied by an increase of EtCO 2 pressure measured by capnography. At baseline, the mean EtCO 2 value is 39.9 + 1.6 mmHg and rises to 49 + 1.2 mmHg. With fMRI, the EtCO 2 trace is followed by an increase of BOLD signal (figure 2-a).
With fNIRS, the EtCO 2 trace is also followed by an increase of HbO and a decrease of HbR With the temporal EtCO 2 trace correctly shifted to match the HbO, oxygenation or HbR variation, we can measure the correlation between these parameters. Figure 3 shows an example of linear relationship between HBO/HbR and the EtCO 2 trace. In figure 6 , we plotted for each individual global CVR values acquired with fMRI (x-axis) versus CVR values via fNIRS (y-axis). We see a moderate correlation between the two modalities with a Pearson's correlation of 0.47 (p= 0.001).
DISCUSSION
CVR in healthy volunteers
In this study, we were able to measure and quantify CVR with two different imaging modalities, fNIRS and fMRI, in a cohort of HC and chronic moderate-severe TBI subjects. CVR measures with fNIRS can be reliably obtained from HbO, HbR or a combination of both (oxygenation= HbO-HbR). The inter-channel variations in CVR and the inter-subject's variation in CVR were the lowest with the oxygenation signal. The variation of HbO and HbR signal between patients during hypercapnea were also noticed in Sleb's paper 53 with a contrast to noise ratio (CNR) lower than 1. In our study, CNR for the HC group is 3.0 for HbO, 2.6 for HbR and 3.1 for oxygenation. This difference can be explained by a longer hypercapnia duration in our study (60s) than that used in the previous report. Indeed, the EtCO 2 graph (figure2) shows that a plateau is reached after 30s, which suggests that a period of 30s, as used with Sleb's study, seems insufficient to reach a full CVR response. Also, with fMRI, several studies used a long hypercapnia period to study CVR with interval step changes of 60s 43 , 120s 54, 55 and 440s 13 without high inter-subject variability in the whole CVR. 13 Our fNIRS and fMRI results also suggest that a moderate (5% CO 2 ) and longer duration hypercapnia challenge (60s or longer) is needed to observe a change of blood flow. Our moderate CO 2 concentration can explain why Virtanen et al 56 didn't observe a significant HbO or HbR response to a 2% and 3% CO 2 increase with an estimated CNR lower than 1 for HbO and HbR.
The goal of our study was to identify vascular lesions, via CVR, in TBI patients with fNIRS and compare it with measures obtained using MRI-BOLD. BOLD signal is known to better fit HbR than HbO and a true comparison of the two techniques should only be done with HbR 57, 58 .
However with the increase of HbO and the decrease of HbR during our challenge, we found the best discriminating parameter is the difference between the two signals. HbT (HbO + HbR) or SO 2 (HbO/HbT) are also two parameters frequently used 59 to quantify blood change, but they usually have a high CNR.
Moreover, the response of hypercapnia should be correlated with the EtCO 2 trace to measure the individual response to CVR. Even if the variability of EtCO 2 trace between patients is low, the range of amplitude of EtCO 2 between room air and 5% CO 2 varies between 8 to 11 mmHg, which can induce a high variability in hemodynamic response. In our study, the hemodynamic signal is normalized with EtCO 2 trace and it can be a reason for our low inter-subject variability.
CVR in TBI
CVR is a biomarker for vascular injury after TBI 40, 60 , which is more sensitive in discriminating TBI subjects from HC than CBF. While CVR with fMRI has already been studied, 40, 54 this is the first time CVR was measured with fNIRS in TBI. Both modalities were able to distinguish CVR abnormalities between the two groups.
While nearly all TBI subjects had abnormalities detectable on structural imaging (MPRAGE, FLAIR), most of the regions of low CVR appeared in normal-appearing brain regions with structural MRI. 40 CVR (with fMRI) maps show asymmetries in the chronic TBI population that reliably differentiates them from HC. In areas of visible encephalomalacia on structural MRI, we noted a decrease in CVR. With fNIRS with 16 channels, asymmetric CVR map were also observed and the presence of encephalomalacia in the frontal cortex was associated with low CVR ( figure 5) , an expected finding which provides internal validity to this measure. From an individual measure perspective, the 16 channel device is able to detect vascular deficits in the prefrontal cortex and, like our previous study in fMRI 40 , we detect focal vascular deficits in patients with or without visible structural lesions on the FLAIR. However, due to the multifocal nature of the vascular injury, subjects with TCVI primarily in non-frontal regions, will not be identified with the fNIRS instrument employed in this study, which was limited to the frontal regions.
The two modalities are moderately correlated ( figure 6 ), even using the global CVR value measured by fMRI. It was not possible to correlate fNIRS CVR with CVR in the frontal cortex with fMRI, due to the high variance of regional CVR measures. As was shown by Yezhuvath 13 , large inter-subject variations in CVR were observed between ROIs, often manifesting a two-fold difference. The inter-subject variations in CVR are likely not simply noise, but may reflect different global physiologic status in different subjects. A solution to solve this problem is to divide the voxel-or ROI CVR values by the whole brain CVR, 13 an approach that is not appropriate in our study due to the multifocal nature of vascular deficits after TBI.
In summary, this study shows that CVR, a dynamic measure of microvascular function, is a sensitive biomarker of TCVI in chronic moderate/severe TBI. CVR can be obtained with fNIRS or fMRI, and each modality has both advantages and disadvantages: fMRI is the gold standard with a high resolution which can be co-localized with any structural images, but NIRS has a better temporal resolution, with a low cost and easily transferred in outpatient facilities. Using fNIRS for CVR measurement shows promise as an adjunct tool in the diagnostic assessment of TBI but also as a predictive and pharmacodynamic biomarker for interventions targeting TCVI. Figure 6 : Correlation between the global CVR measured with fMRI and CVR measured with fNIRS (from the oxygenation data) for each subject. The red dot represent subject from the TBI group and the blue dot are subject for the HC group. The Pearson's correlation between the two modalitie is R = 0.47 (p=0.001). Table 1 : Demographics, TBI characteristics, and neurobehavioral symptom survey analysis. BSI global is defined as the sum of BSI vestibular, BSI somatic, BSI depression and BSI anxiety. TBI = traumatic brain injury; HC = healthy control; STD = standard deviation; IQR = interquartile range (25th and 75th); LOC = loss of consciousness; GOS-E = Glasgow Outcome Scale-Extended.
TBI (n=27) HC (N=15) p
Age, mean (std) 38 Abnormal images (%) 87.5
Days in ICU (days), median (IQR) 6 (3, 14) GOS-E, median (IQR) 7 (6, 7)
BSI (total), median (IQR) 3 (1.5, 4.7) 0.25 (0, 1) <0.001 BSI Vestibular, median (IQR) 0 (0, 2) 0 (0, 0) 0.003 BSI Somatic, median (IQR) 3 (2, 4) 0 (0, 2) 0.001 BSI Cognitive, median (IQR) 2 (0.25, 7) 0 (0, 0.75) 0.005 BSI Affective, median (IQR) 4 (0, 7) 0 (0, 1) 0.005 
